Pharma & Biotech

Bayer shareholders face renewed pressure as another court ruling delivers a substantial blow. A $600 million damages award has been...

Viking Therapeutics stands at a pivotal moment in its corporate trajectory. The biotechnology firm has initiated a new maintenance study...

The biotechnology sector is witnessing remarkable momentum in Assembly Biosciences stock, which has now advanced for six consecutive trading sessions....

Alnylam Pharmaceuticals continues its impressive market performance, consistently reaching new valuation heights. However, this upward trajectory hasn't convinced all market...

Institutional investors are demonstrating significant confidence in Sarepta Therapeutics through recent strategic moves. Privium Fund Management B.V. established a new...

The biotechnology sector is witnessing the emergence of a formidable player as Arrowhead Pharmaceuticals capitalizes on a landmark collaboration with...

The biotechnology sector has witnessed the emergence of a standout performer: Ocugen. This gene therapy enterprise is demonstrating remarkable momentum,...

Shares of Adaptimmune Therapeutics experienced a devastating collapse, plummeting more than 70% during yesterday's trading session. This dramatic sell-off was...

Eli Lilly has captured market attention with two significant clinical achievements that position the pharmaceutical giant for substantial growth. While...

A convergence of positive developments has propelled Gilead Sciences shares to unprecedented levels, with three separate strategic achievements within days...